These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16369935

  • 21. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease.
    Westenfeld R, Schlieper G, Wöltje M, Gawlik A, Brandenburg V, Rutkowski P, Floege J, Jahnen-Dechent W, Ketteler M.
    Nephrol Dial Transplant; 2011 Dec; 26(12):4115-23. PubMed ID: 21622987
    [Abstract] [Full Text] [Related]

  • 22. Pharmacodynamics of T-cell function for monitoring immunosuppression.
    Barten MJ, Tarnok A, Garbade J, Bittner HB, Dhein S, Mohr FW, Gummert JF.
    Cell Prolif; 2007 Feb; 40(1):50-63. PubMed ID: 17227295
    [Abstract] [Full Text] [Related]

  • 23. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
    Han CH, Li HF, Wang YX, Zhang M, Wang Y, Yin M, Min ZL, Zheng KL.
    Zhonghua Yi Xue Za Zhi; 2005 May 25; 85(19):1327-32. PubMed ID: 16029632
    [Abstract] [Full Text] [Related]

  • 24. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
    Hutchinson P, Jose M, Atkins RC, Holdsworth SR.
    Transpl Immunol; 2004 May 25; 13(1):55-61. PubMed ID: 15203129
    [Abstract] [Full Text] [Related]

  • 25. Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
    Diekmann F, Gutiérrez-Dalmau A, López S, Cofán F, Esforzado N, Ricart MJ, Rossich E, Saval N, Torregrosa JV, Oppenheimer F, Campistol JM.
    Nephrol Dial Transplant; 2007 Aug 25; 22(8):2316-21. PubMed ID: 17452413
    [Abstract] [Full Text] [Related]

  • 26. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O, Jiménez O, Fortuna V, Barceló JJ, Brunet M.
    Int J Immunopathol Pharmacol; 2006 Aug 25; 19(2):317-30. PubMed ID: 16831299
    [Abstract] [Full Text] [Related]

  • 27. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC, Eugui EM.
    Clin Transplant; 1996 Feb 25; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [Abstract] [Full Text] [Related]

  • 28. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients.
    Barten MJ, Rahmel A, Garbade J, Richter M, Bittner HB, Dhein S, Mohr FW, Gummert JF.
    Transplant Proc; 2005 Mar 25; 37(2):1360-1. PubMed ID: 15848720
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil ameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr/lpr mice.
    Jonsson CA, Erlandsson M, Svensson L, Mölne J, Carlsten H.
    Cell Immunol; 1999 Nov 01; 197(2):136-44. PubMed ID: 10607431
    [Abstract] [Full Text] [Related]

  • 30. Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.
    Schachter AD, Meyers KE, Spaneas LD, Palmer JA, Salmanullah M, Baluarte J, Brayman KL, Harmon WE.
    Pediatr Transplant; 2004 Apr 01; 8(2):171-7. PubMed ID: 15049798
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients.
    Weimer R, Mytilineos J, Feustel A, Preiss A, Daniel V, Grimm H, Wiesel M, Opelz G.
    Transplantation; 2003 Jun 27; 75(12):2090-9. PubMed ID: 12829918
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
    Sampaio EL, Pinheiro-Machado PG, Garcia R, Felipe CR, Park SI, Casarini DE, Moreira S, Franco MF, Tedesco-Silva H, Medina-Pestana JO.
    Clin Transplant; 2008 Jun 27; 22(2):141-9. PubMed ID: 18339132
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.